Anti-annexin V antibodies in Takayasu's arteritis: Prevalence and relationship with disease activity

Clinical and Experimental Immunology

Volumn 134, Issue 2, 2003, Pages 360-364

  Tripathy, N K ^a   Sinha, N ^a   Nityanand, S ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anti annexin V antibodies; Disease activity; Takayasu's arteritis

Indexed keywords

CARDIOLIPIN ANTIBODY; CELL ANTIBODY; ENDOTHELIAL CELL ANTIBODY; LIPOCORTIN 5 ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; AORTA ARCH SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; ANNEXIN A5; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TAKAYASU'S ARTERITIS;

EID: 0242539933     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02282.x     Document Type: Article

References (42)

1. Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am 1995; 21:1041-58.
2. Brogan PA, Dillon MJ. Vasculitis from the pediatric perspective. Curr Rheumatol Rep 2000; 2:411-6.
3. Noris M. Pathogenesis of Takayasu's arteritis. J Nephrol 2001; 14:506-13.
4. Filer A, Nicholls D, Corston R et al. Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 2001; 28:2752-3.
5. Stefanes T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 2000; 117:841-54.
6. Bombeli T, Karsan A, Tait JF et al. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89:2429-42.
7. Van Heerde WL, de Groot PG, Reutelingsperger CP. The complexity of the phospholipid binding protein annexin V. Thromb Haemost 1995; 73:172-9.
8. Reutelingsperger CP, van Heerde WL. Annexin V, the regulator of phosphatidylserine catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 1997; 53:527-32.
9. Speijer H, Jans SW, Reutelingsperger CP et al. Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2. FEBS Lett 1997; 402:193-7.
10. c+ membrane particles in a human T lymphocyte model. J Immunol 1999; 162:5712-8.
11. 2+ influx in human lymphocytic T cells. Biochem Biophys Res Commun 1999; 265:709-15.
12. Nakamura N, Shidara Y. Kawaguchi N et al. Lupus anticoagulant antibody induces apoptosis in umbilical vein indothelial cells: involvement of annexin V. Biochem Biophys Res Commun 1994; 205:1488-93.
13. Nakamura N, Ban T, Yamaji K et al. Localization of apoptosis inducing activity in lupus-anticoagulant in an annexin V binding antibody subset. J Clin Invest 1998; 101:1951-9.
14. Praprotnik S, Blank M, Meroni PL et al. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. The pathogenic and diagnostic implications. Arthritis Rheum 2001; 44:1484-94.
15. Nakamura N, Kuragaki C, Shidara Y et al. Antibody to annexin V has anti-phospholipid and lupus anti-coagulant properties. Am J Hematol 1995; 49:347-8.
16. Matsuda J, Saitoh N, Gohchi K et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anti-coagulant and/or anti-cardiolipin antibody. Am J Hematol 1994; 47:56-8.
17. Kaburaki J, Kuwana M, Yamamoto M et al. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 1997; 54:209-13.
18. Nityanand S, Mishra K, Shrivastava S et al. Autoantibodies against cardiolipin and endothelial cells in Takayasu's arteritis: prevalence and isotype distributron. Br J Rheumatol 1997; 36:923-4.
19. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33:1129-34.
20. Rodriguez-Garcia MI, Fernandez JA, Rodriguez A et al. Annexin V autoantibodies in rheumatoid arthritis. Ann Rheum Dis 1996; 55:895-900.
21. Matsuda J, Gotoh M, Saitoh N et al. Anti-annexin V antibody in the sera of patients with habitual fetal loss or preeclempsia. Thromb Res 1994; 75:106-6.
22. Nojima J, Kuratsune H, Suehisa E et al. Association between the prevalence of antibodies to α2-glycoprotein I. prothrombin, protein C, protein S and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 2001; 47:1008-15.
23. Satoh A, Sujuki K, Takayama E et al. Detection of anti-annexin IV and V antibodies in patients with anti-phospholipid syndrome and systemic lupus erythematosus. J Rheumatol 1999; 26:1715-20.
24. Ogawa H, Zhao D, Dlott JS et al. Elevated anti-annexin V antibody levels in anti-phospholipid syndrome and their involvement in anti-phospholipid antibody specificities. Am J Clin Pathol 2000; 114:619-28.
25. Lakos G, Kiss E. Regeczy N et al. Anti-prothrombin and anti-annexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J Rheumatol 2000; 27:924-9.
26. Arnold J. Holmes Z, Pickering W et al. Anti-beta2 glycoprotein1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 2001; 113:911-4.
27. Matsubayashi H, Arai T, Izumi S et al. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failures. Fertil Steril 2001; 76:694-9.
28. Dubois T, Bisagni-Faure A, Coste J et al. High levels of antibodies to annexins V and VI in patients with rheumatoid arthritis. J Rheumatol 1995; 22:1230-4.
29. Sugiura K, Muro Y. Anti-annexin V antibodies and digital ischemia in patients with scleroderma. J Rheumatol 1999; 26:2168-72.
30. Gaspersic N, Rot U, Cucnik S et al. Anti-annexin V antibodies in patients with cerebrovascular disease. Ann Rheum Dis 2003; 62:188-9.
31. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002; 126:1424-9.
32. Bordron A, Revelen R, D'Arbonneau M et al. Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 2001; 124:492-501.
33. Haviv YS. Association of anticardiolipin antibodies with vascular injury: possible mechanisms. Postgrad Med J 2000; 76:625-8.
34. Goulding NJ, Podgorski MR, Hall ND et al. Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1989; 48:843-50.
35. Jorgensen CS, Levantino G, Houen G et al. Determination of autoantibodies to annexin XI in systemic autoimmune diseases. Lupus 2000; 9:515-20.
36. Clancy R, Marder G, Martin V et al. Circulating activated endothelial cells in systemic lupus erythematosus. Further evidence for diffuse vasculopathy. Arthritis Rheum 2001; 44:1203-8.
37. Trouve P, Legot S, Belilcova I et al. Localization and quantitation of cardiac annexins II, V and VI in hypertensive guinea pigs. Am J Physiol 1999; 276:H1159-66.
38. Ohkawara M, Kuroiwa T, Numano F. Immunohistochemical studies on annexin I and II in Takayasu arteritis. Ann NY Acad Sci 2001; 947:390-3.
39. Kirsch T, Nah HD, Demuth DR et al. Annexin V mediated calcium flux across membranes is dependent on the lipid composition: Implication for cartilage mineralization. Biochemistry 1997; 36:3359-67.
40. Mevorach D. Opsonization of apoptotic cells: implications for uptake and immunity. Ann NY Acad Sci 2000; 926:226-35.
41. Wang X, Campos B. Kaetzel MA et al. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999; 180:1008-16.
42. Di Simone N, Castellani R, Caliandro D. et al. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2001; 65:1766-70.